Asthma Respiratory Asthma
Conditions
Interventions
Current interventions as of 05/06/2019:
This study will be divided into two parts, which involves
1. the development of a pictorial asthma action plan, and
Sponsors
University of Edinburgh
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Known asthma diagnosed by a healthcare practitioner 2. Taking inhaled corticosteroids 3. Aged 18 years and older 4. Able to understand the Malay and English languages
Exclusion criteria
Exclusion criteria: 1. Known colour-blindness. 2. Severe exacerbations requiring admission. 3. Known self-reported condition prohibiting participation such as cognitive impairment, and severe communication problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 05/06/2019: 1. Asthma control as measured by GINA Asthma symptom control at baseline and 1-, 3-, 6- and -12 month post intervention. 2. Whether study participation leads to serious negative consequences for participants. 3. Any serious concerns about the acceptability and feasibility of the trial procedures that can be rectified prior to a full trial. 4. Whether follow up data is available from at least 60% of participants at 12 months post intervention. Previous primary outcome measures: 1. Asthma control is measured using ACQ mean score at baseline and 1-, 3-, 6- and -12 month post intervention. 2. Whether trial participation leads to serious negative consequences for participants. 3. Any serious concerns about the acceptability and feasibility of the trial procedures that can be rectified prior to a full trial. 4. Whether follow up data is available from at least 60% of participants at 12 months post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Unscheduled health care utilization will be measured using patient interview via telephone call and from the patient’s medical notes at baseline and 1-, 3-, 6- and -12 month post intervention. 2. Number of courses of oral steroids used will be measured using patient interview via telephone call and from the patient’s medical notes at baseline and 1-, 3-, 6- and -12 month post intervention. 3. Hospitalization will be measured using patient interview via telephone call and from the patient’s medical notes at baseline and 1-, 3-, 6- and -12 month post intervention. 4. Frequency of reliever medication use will be measured using patient interview via telephone call and from the patient’s medical notes at baseline and 1-, 3-, 6- and -12 month post intervention. 5. Frequency of controller medication use will be measured using patient interview via telephone call and from the patient’s medical notes at baseline and 1-, 3-, 6- and -12 month post intervention. 6. Frequency of utilizing the brief pictorial asthma plan will be measured using patient interview via telephone call and from the patient’s medical notes at baseline and 1-, 3-, 6- and -12 month post intervention. 7. Number of routine follow up appointments will be measured using patient interview via telephone call and from the patient’s medical notes at baseline and 1-, 3-, 6- and -12 month post intervention. | — |
Countries
Malaysia
Outcome results
None listed